Cure8 research brief
Identifying simple features at diagnosis that predict a disabling 5‑year course could help patients and clinicians plan monitoring and treatment intensity earlier after Crohn’s diagnosis.
Newly diagnosed adult Crohn’s patients, gastroenterologists and IBD clinicians, and researchers studying prognostic markers in IBD.
The study analyzed 814 patients from 32 hospitals and defined “disabling” disease as need for hospitalization for flare/complication, start of immunomodulators or biologics, intestinal resection, or perianal surgery within 5 years. Independent predictors at diagnosis were age under 40, initial need for corticosteroids, and jejunal involvement.
Presence of perianal disease was not predictive in this cohort, differing from some prior reports. How this might be used: If validated prospectively, these easily assessed clinical features could help clinicians identify higher‑risk patients for closer monitoring or earlier therapy escalation. They do not on their own prescribe a treatment change.
This is a retrospective, preprint-level cohort study from Korea; the authors recommend further prospective validation before these predictors are used to guide care decisions.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Reducing long-term corticosteroid use matters because steroids have significant side effects when used repeatedly or chronically. The study suggests ileocaecal resection may lower steroid exposure for many patients, but...
This trial is testing whether adding vedolizumab after autologous stem cell transplant can improve remission rates for people with severe Crohn's disease that has failed multiple therapies.
This study suggests that regional differences in how often and how early advanced drugs are used didn’t change 10-year rates of surgery, hospitalization, or progression to complicated Crohn’s disease in this cohort.
